RHI Magnesita

Stefan Borgas appointed new CEO as of December 1, 2016 for five years

  Disclosed inside information pursuant to article 17 Market Abuse Regulation
  (MAR) transmitted by euro adhoc with the aim of a Europe-wide distribution.
  The issuer is solely responsible for the content of this announcement.
Board of Directors (Appointments and Changes)

At its meeting on September 26, 2016, the Supervisory Board of RHI AG appointed
Mr. Stefan Borgas, Lic. Oec. (HSG) new CEO with effect from December 1, 2016. In
order to enable an orderly handover of tasks, Dr. Wolfgang Ruttenstorfer will
continue to be available as interim Chairman of the Management Board until
November 30, 2016.
Mr. Franz Struzl will resign as member of the Management Board with the expiry
of November 30, 2016 and act as a consultant to the company once he has fully
Having studied business management at the University of Saarbrücken and the
University of St. Gallen, Stefan Borgas, 52, started his career in the chemical
industry. After joining BASF, he held several management positions in the US,
Germany and China and was responsible as Vice President for the business unit
"Fine Chemicals" from 2002. In 2004, he was appointed CEO in the Management
Board of the Swiss Lonza Group and transformed the company into a leading life
science group. In 2012, he joined the special chemicals manufacturer Israel
Chemicals Ltd. as President & CEO.

Further inquiry note:
Investor Relations
Mag. Simon Kuchelbacher
Tel: +43-1-50213-6676
Email: simon.kuchelbacher@rhi-ag.com

end of announcement                               euro adhoc 

issuer:      RHI AG
             Wienerbergstrasse 9
             A-1100 Wien
phone:       +43 (0)50213-6676
FAX:         +43 (0)50213-6130
mail:     rhi@rhi-ag.com
WWW:      http://www.rhi-ag.com
sector:      Refractories
ISIN:        AT0000676903
indexes:     ATX Prime, ATX
stockmarkets: official market: Wien 
language:   English

Original-Content von: RHI Magnesita, übermittelt durch news aktuell

Weitere Meldungen: RHI Magnesita

Das könnte Sie auch interessieren: